Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Hassan R, Kindler HL, Jahan T, Bazhenova L, Reck M, Thomas A, Pastan I, Parno J, O'Shannessy DJ, Fatato P, Maltzman JD, Wallin BA

Publication

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1183907

Publication Year

2014

PubMed ID

25231400